FreeMind Group is happy to support Biotech Showcase 2018!
Where: San Francisco, CA
When: January 8-10, 2018
- This exclusive biotech investor conference is taking place during healthcare’s most important week
- Meet 3,500+ C-level executives including 900+ Investors
- More than $334 billion in capital represented
- 400 public and private company presentations
- Panels and sessions, including top industry leaders
- Preschedule one-to-one investor and partnering meetings
INVESTOR REGISTRATIONS ARE UP 60% OVER LAST YEAR!
Biotech Showcase 2018 | January 8–10 | San Francisco, California
#BTS18
FreeMind is pleased to support the upcoming Life Sciences Summit!
Where: New York City, NY
When: November 1-2, 2017
The Life Sciences Summit is an early-stage investor and business development conference for emerging companies and academic innovators. The objective of the meeting is to connect emerging companies with early-stage investors, business development professionals, and medical research foundations with the goal of advancing new innovations through clinical development.
The Summit provides emerging companies and academic innovators with exposure to potential investors and strategic partners through
- Emerging Company Showcase
- Pitch Doctor Sessions
- Pipeline Café
- Business Workshops & Plenary Sessions
- Therapeutic Focused Panels
- Online & Onsite Partnering
- Strategic Partners Presentations
The Life Sciences Summit is the premier meeting dedicated to bringing emerging companies and innovators together with capital and industry in a setting that facilitates collaboration and networking.
Visit www.lifesciencessummit.org to learn more.
FreeMind Group is proud to support BioFIT 2017!
Where: Strasbourg, France
When: November 28-29, 2017
As you may know, the 6th edition of BioFIT will take place on 28th and 29th November in Strasbourg. BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage innovation and seed investment in the field of Life Sciences. With more than 1,200 international leading actors from 35+ countries, the event gathers big pharma, emerging and small biotech companies, pre-seed/seed/Series A investors, as well as professionals from tech transfer, academia and research institutions.
Many key players have already confirmed their presence, including Pfizer, AbbVie, J&J, Sanofi, Roche, GSK, Novo Nordisk, Pierre Fabre, AstraZeneca, Lilly, Bayer, Merck, Servier, Janssen Pharmaceutica, Evotec, Lonza, Ipsen, Boehringer Ingelheim, Genfit, Transgene, Sofinnova Partners, Onxeo, Debiopharm, Kurma Partners, VIB, Novo Seeds, European Investment Fund, Max Planck Institute, MRC Technology, Ascenion, Isis Innovation…
Use our network code BF17_FREEMINDS% for a 25% discount!
FreeMind is a proud supporter of the upcoming Inv€$tival Showcase
Where: London, UK
When: November 14, 2017
Showcasing innovative investable Biotech, Medtech and Digital Health investment and partnering opportunities.
Biotech and Money connects corporates to capital, and the Inv€$tival Showcase is our most direct way of showcasing the latest investable private and public life science opportunities to our growing investor network, and that of our partners, Jefferies LLC.
The 4 track Inv€$tival Showcase is designed to highlight the latest innovative companies who are looking to raise capital and their profile amongst investors, and provide an unparalled opportunity for 1-2-1 investor and B2B meetings in a unique setting, and as part of the week of the Jefferies Global Healthcare conference in London. The 4 tracks are split into industry sub-sectors, with sections for companies working within the fields of immuno-oncology, cell and gene therapy, precision medicine, neuroscience / CNS, orphan drugs, digital health and medical devices, as well as an agnostic section for other industry sub-sectors. Presenting companies will range from the latest start-ups through to growing public companies, delivering succinct powerful presentations to an audience of qualified investors.
FreeMind is pleased to support The MedTech Conference powered by AdvaMed
Where: San Jose, CA
When: September 25-27, 2017
The MedTech Conference powered by AdvaMed is the leading gathering in North America of global medtech executives with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance, HR and other key responsibilities. Along with industry leaders, the international conference attracts business development professionals, investors, policy-makers, members of the media, legal experts, consultants, distributors, and other important stakeholders.
More than 2,500 attendees will network, conduct business, gain access to capital and share insights in San Jose, California from September 25-27. The conference also features world-class plenary speakers, networking, and business development opportunities. Visit www.themedtechconference.com to learn more.
We all had an amazing week in San Diego, seeing hundreds of new and familiar faces!
FreeMind was quite pleased to give away 5 bottles of Grants Whisky this year and we look forward to helping our clients win hundreds of thousands of dollars in governments grants before the year is out.
Two lucky winners: Mary Syto, Director, Clinical Operations at Receptos and
Sam Mercer, Director of Outsourcing and Business Development at Eupraxia Pharmaceuticals.
FreeMind is proud to support the upcoming Investment for Advanced Therapies event!
When: May 3, 2017
Where: London, UK
Investment for Advanced Therapies will be the C-Level meeting place for heavyweight investors, analysts, biotechs, venture partners and industry experts who are driving the industry forward. Don’t miss your chance to shape the future and put your company on the map!
This one-day, highly interactive program will:
• Explain the market outlook and address specific questions regarding investment and licensing opportunities in advanced therapies
• Provide institutional, strategic and venture investors with unique insight into financing hypothesis for advanced therapies
• Showcase a cross section of early stage, pre-IPO, late stage and public biotech companies and provide extensive networking opportunities
• Introduce senior executives from biopharmaceutical companies to explain how investors can profit from the development of the advanced therapies franchise
• Promote and facilitate investment, financing, partnerships and deal making in the cell and gene therapy field
Visit here for more information.